Anagenex is building a novel platform for drug discovery focusing on difficult targets.

Anagenex's technology analyzes 100-1000x more compounds compared to traditional approaches by combining machine learning with DNA Encoded Libraries.
-
Industry
-
Milestones
- Lux investment: 2019
-
Founders
- Nicolas Tilmans, PhD
- Zavain Dar
LUX Partners
-
Latest Tweets
- Thrilled to be a part of this year’s @stateofaireport by @nathanbenaich and @soundboy. There's a lot going on in AI… https://t.co/BrcdiWIq5F
- Welcome to @Edsn_Aguiar , our first hire in DevOps! He has worked on numerous containerization, automation and orch… https://t.co/2R94XGhNjD
- Welcome to @barb_ernisse as our Director of Lab Operations. Barb has seen all aspects of the lab from bench researc… https://t.co/ZTSsmrYOvi